Innovations in Bacteriophage Genome Engineering for Combating Multidrug-Resistant Bacterial Infections

Area of Science:

• Microbiology
• Synthetic Biology
• Infectious Diseases

Background:

• Multidrug-resistant (MDR) bacterial infections are a major public health threat, driven by antibiotic overuse.
• Bacteria develop resistance to antibiotics and phage therapy through mechanisms like receptor modification and antiviral defenses.
• Long-term phage therapy can elicit anti-phage antibodies, potentially limiting treatment effectiveness.

Purpose of the Study:

• To explore bacteriophage engineering as a strategy to overcome MDR bacterial infections.
• To investigate advanced genome engineering techniques for enhancing phage efficacy and host range.
• To understand phage-host interactions for guiding engineering efforts.

Main Methods:

• Utilizing genome engineering methods such as CRISPR/Cas9 and homologous recombination.
• Applying synthetic biology techniques to modify bacteriophages.
• Employing high-yield screening methods for phage optimization.
• Studying bacteriophage-bacterial host interactions.

Main Results:

• Engineered bacteriophages demonstrate improved efficacy against MDR bacteria.
• Modifications to receptor-binding proteins enhance phage targeting capabilities.
• Synthetic biology approaches enable the expansion of phage host range.
• Understanding phage-host dynamics is crucial for successful engineering.

Conclusions:

• Bacteriophage engineering presents a powerful strategy to combat MDR bacterial infections.
• Advanced genome engineering and synthetic biology are key to overcoming therapeutic challenges.
• Integrating engineered bacteriophages into clinical practice holds significant potential for future infectious disease treatment.